Delveinsight

Otitis Media Market Insights, Epidemiology and Market Forecast-2028

DelveInsight Business Research LLP

 

Albany, NY -- (SBWIRE) -- 06/19/2019 -- Otitis Media Market Insights, Epidemiology and Market Forecast-2028

19 June 2019

1. Acute Otitis Media is the most common condition with high morbidity and low mortality.
2. Otitis Media Prevalence is slightly higher in males than in females.
3. About 3 out of 4 children have at least one episode of Otitis Media by 3 years of age.

(Albany, US) DelveInsight launched a new report on Otitis Media Market Insights, Epidemiology and Market Forecast-2028
Request for sample pages

Key benefits

1. Otitis Media market report covers a descriptive overview and comprehensive insight of the Otitis Media epidemiology and Otitis Media market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Otitis Media market report provides insights into current and emerging therapies.
3. Otitis Media market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Otitis Media market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Otitis Media market.

Request for sample pages

"There was a decline of 28% between 1997 and 2007, from 345 to 247 per 1000 children younger than 18 years in the US owing to the introduction of pneumococcal conjugate vaccines and the guidelines encouraging primary care providers to use more stringent criteria in diagnosing Acute Otitis Media."

The increasing Otitis Media prevalence, particularly Acute Otitis Media (AOM) and Otitis Media with Effusion (OME) propels the Otitis Media treatment and management Otitis Media market. The current Otitis Media therapeutic regimen includes symptomatic treatment, antibiotic treatment, topical and oral analgesics along with medical and supportive care to control pain and Otitis Media symptoms.

The use of certain antibiotics in Otitis Media treatment is limited and thus affecting the Otitis Media market and projecting serious unmet medical need. However, this also provides a great platform for the upcoming novel therapies to grab a significant Otitis Media market share.

To redress the current issues, the companies are currently working on novel therapies targeted for the Otitis Media treatment and its prevention in recurrent cases. The other factors that shall further fuel the growth of Otitis Media market include increased understanding about the disease, introduction of novel targeted Otitis Media therapies in the market and other innovative Otitis Media treatment options to overcome the limitation of current treatment regimen and improved patient of care. These all will contribute towards the Otitis Media market growth during the forecast period (2019-2028).

Otitis Media market dynamics are set to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world and expected the launch of Otitis Media emerging therapies during the forecast period of 2019-2028. Companies across the globe are working towards the development of new therapies for Otitis Media treatment.

The key players in Otitis Media market are:

1. Novus Therapeutics
2. Yuhan Corporation
3. Lee's Pharmaceuticals
And many others

Drugs covered

1. YH1177
2. OP0201
And many others

Table of contents

1. Otitis Media Report Introduction
2. Otitis Media Market Share at a glance
3. Otitis Media Disease Background and Overview
4. Otitis Media Epidemiology and Patient Population
5. Otitis Media Epidemiology Country Wise
5.1. United States
5.2. EU5
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.Spain
5.2.5.United Kingdom
5.3. Japan
6. Otitis Media Current Treatment & Medical Practices
6.1. Guidelines and Recommendations for Otitis Media Treatment
6.1.1.United States
6.1.2.Europe
6.1.3.Japan
7. Otitis Media Current Unmet Needs
8. Otitis Media Marketed Drugs
8.1. Otipriotm (ciprofloxacin otic suspension): Otonomy
9. Otitis Media Emerging Therapeutics
10. Key Cross Competition
10.1. OP0201: Novus Therapeutics
10.2. YH1177: Yuhan Corporation
11. Otitis Media Market Size
11.3. United States
11.4. EU-5
11.4.1. Germany
11.4.2. France
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.5. Japan
12. Market Drivers
13. Market Barriers
14. Appendix
15. Otitis Media Report Methodology
16. DelveInsight Capabilities
17. Disclaimer
18. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight